PFRM3 Stock Chart & Stats
R$6.92
R$0.14(2.06%)
―
--
Day’s Range― - ―
52-Week RangeR$6.11 - R$9.70
Previous CloseN/A
VolumeN/A
Average Volume (3M)128.09K
Market Cap
R$831.30M
Enterprise ValueR$2.59K
Total Cash (Recent Filing)R$487.77M
Total Debt (Recent Filing)R$1.90B
Price to Earnings (P/E)8.0
Beta1.03
Next Earnings
Oct 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.27
Shares Outstanding123,812,775
10 Day Avg. Volume103,190
30 Day Avg. Volume128,090
Financial Highlights & Ratios
PEG Ratio2.19
Price to Book (P/B)0.83
Price to Sales (P/S)0.10
P/FCF Ratio5.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PFRM3 FAQ
What was Profarma Distribuidora de Produtos Farmaceuticos SA’s price range in the past 12 months?
Profarma Distribuidora de Produtos Farmaceuticos SA lowest stock price was R$6.11 and its highest was R$9.70 in the past 12 months.
What is Profarma Distribuidora de Produtos Farmaceuticos SA’s market cap?
Profarma Distribuidora de Produtos Farmaceuticos SA’s market cap is R$831.30M.
When is Profarma Distribuidora de Produtos Farmaceuticos SA’s upcoming earnings report date?
Profarma Distribuidora de Produtos Farmaceuticos SA’s upcoming earnings report date is Oct 28, 2026 which is in 87 days.
How were Profarma Distribuidora de Produtos Farmaceuticos SA’s earnings last quarter?
Profarma Distribuidora de Produtos Farmaceuticos SA released its earnings results on Jul 29, 2026. The company reported R$0.578 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Profarma Distribuidora de Produtos Farmaceuticos SA overvalued?
According to Wall Street analysts Profarma Distribuidora de Produtos Farmaceuticos SA’s price is currently Undervalued.
Does Profarma Distribuidora de Produtos Farmaceuticos SA pay dividends?
Profarma Distribuidora de Produtos Farmaceuticos SA does not currently pay dividends.
What is Profarma Distribuidora de Produtos Farmaceuticos SA’s EPS estimate?
Profarma Distribuidora de Produtos Farmaceuticos SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Profarma Distribuidora de Produtos Farmaceuticos SA have?
Profarma Distribuidora de Produtos Farmaceuticos SA has 123,812,775 shares outstanding.
What happened to Profarma Distribuidora de Produtos Farmaceuticos SA’s price movement after its last earnings report?
Profarma Distribuidora de Produtos Farmaceuticos SA reported an EPS of R$0.578 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 9.355%.
Which hedge fund is a major shareholder of Profarma Distribuidora de Produtos Farmaceuticos SA?
Currently, no hedge funds are holding shares in BR:PFRM3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Profarma Distribuidora de Produtos Farmaceuticos SA
Established in 1961 and headquartered in Rio de Janeiro, Brazil, Profarma Distribuidora de Produtos Farmacêuticos S.A. is a prominent player in the Brazilian healthcare market, focusing on both the wholesale and retail sales of pharmaceutical and hospital supplies. The company's operations are divided into distinct Distribution and Retail segments. Its comprehensive product offerings include a vast array of pharmaceuticals, such as brand-name drugs, generic alternatives, and over-the-counter medications. Profarma also supplies essential hospital products, including injectable and infusion therapies for specialized medical areas like oncology, endocrinology, rheumatology, infectology, and hematology. Furthermore, it provides specific treatments such as vaccines for conditions like influenza, HPV, meningitis, hepatitis, chickenpox, and dengue, alongside specialized medicines for rare and complex diseases. Beyond pharmaceuticals, the company distributes a wide selection of personal care, beauty, and cosmetic items. This category encompasses shampoos, conditioners, treatment creams, hair dyes, baby products like diapers, soaps, deodorants, oral care essentials, sunscreens, men's grooming products, cosmetics, makeup, and skincare. Profarma also features proprietary lines under the Nº21, GOnutri, and Bem Básico brands, offering exclusive hygiene and beauty products, vitamins, and workshop items. Complementing these, convenience goods such as food products, blood pressure monitors, and scales are also available. The company extends its services to include promotional and logistical support, implementation of marketing campaigns, product recall management, development of bespoke solutions for laboratories, and oversight of clinical procedures. As of December 31, 2019, Profarma's infrastructure boasted eleven strategically located distribution centers across several Brazilian states (Alagoas, Bahia, Espírito Santo, Goiás, Minas Gerais, Paraíba, Paraná, Pernambuco, Rio Grande do Sul, Rio de Janeiro, and São Paulo). Its retail footprint comprised approximately 196 stores operating under the Drogarias Tamoio, Drogasmil, Farmalife, and Rede Rosário banners, situated in the states of Rio de Janeiro, Goiás, Tocantins, Mato Grosso, and Distrito Federal.
Profarma Distribuidora de Produtos Farmaceuticos SA (PFRM3) Earnings & Revenues
Allianca Saude e Participacoes SA - ALLIAR
―
D1000 Varejo Farma Participacoes SA
―
Ourofino S.A.
―
Companhia Brasileira de Distribuicao
―
Empreendimentos Pague Menos SA
―